Brokerages Set Astera Labs, Inc. (NASDAQ:ALAB) PT at $348.33

Astera Labs, Inc. (NASDAQ:ALAB) has received a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $348.3333.

ALAB has been the topic of several research reports. Northland Securities raised Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price on the stock in a report on Monday, August 17th. Evercore reiterated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. UBS Group reissued a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Stifel Nicolaus raised their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a report on Wednesday, June 24th. Finally, Barclays lifted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th.

Insider Activity

In other news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares of the company’s stock, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 592,244 shares of company stock worth $209,729,973. 10.40% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Astera Labs

Several hedge funds have recently modified their holdings of ALAB. Greenleaf Trust grew its position in Astera Labs by 1.8% during the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after acquiring an additional 36 shares during the period. Parkside Financial Bank & Trust increased its position in Astera Labs by 74.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after purchasing an additional 41 shares in the last quarter. Glenmede Trust Co. NA raised its holdings in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after buying an additional 51 shares during the period. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs during the second quarter valued at approximately $25,000. Finally, Integrated Wealth Concepts LLC lifted its position in Astera Labs by 0.7% during the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock valued at $3,384,000 after buying an additional 52 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Price Performance

Shares of NASDAQ:ALAB opened at $300.54 on Monday. The business’s 50 day simple moving average is $321.34 and its 200-day simple moving average is $258.86. The firm has a market capitalization of $52.14 billion, a price-to-earnings ratio of 148.78 and a beta of 3.77. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts anticipate that Astera Labs will post 2.7 earnings per share for the current year.

About Astera Labs

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.